首页 › 骨髓增生异常综合征 › 哥伦比亚特区 › Washington
Washington DC 骨髓增生异常综合征临床试验
20项针对 骨髓增生异常综合征的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
招募中2 期
- Walter Reed National Military Medical Center, Bethesda · 距离 7 英里
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
CHIP/CCUS Natural History Protocol
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Natural History Study of GATA2 Deficiency and Related Disorders
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Tissue Samples for Cancer Research
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Children's National Medical Center, Washington D.C.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
招募中2 期
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda · 距离 7 英里
Mosaic Trial for Stem Cell Transplant Recipients
招募中
- Georgetown University School of Medicine, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
招募中观察性研究欢迎健康志愿者
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
招募中观察性研究欢迎健康志愿者
- Cancer Support Community Research & Training Institute, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Silver Spring · 距离 7 英里
- Massive Bio SYNERGY-AI site, Bethesda · 距离 7 英里
其他城市的 骨髓增生异常综合征试验
- Houston, TX43 项研究
- Baldwin Park, CA26 项研究
- New York City, NY21 项研究
- Seattle, WA21 项研究
- Tampa, FL19 项研究
- Boston, MA19 项研究
- Miami, FL17 项研究
- Durham, NC14 项研究
- Columbus, OH14 项研究
- St. Louis, MO13 项研究
- Atlanta, GA13 项研究
- Chicago, IL13 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。